Multiple roles for AU-rich RNA binding proteins in the development of haematologic malignancies and their resistance to chemotherapy

References

• Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31–46. doi: 10.1158/2159-8290.CD-21-1059
   PubMed Web of Science ®Google Scholar
• Pakos-Zebrucka K, Koryga I, Mnich K, et al. The integrated stress response. EMBO Rep. 2016;17(10):1374–1395. doi: 10.15252/embr.201642195
   PubMed Web of Science ®Google Scholar
• Costa-Mattioli M, Walter P. The integrated stress response: from mechanism to disease. Science. 2020;368(6489). doi: 10.1126/science.aat5314
   PubMed Web of Science ®Google Scholar
• Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020;21(8):421–438. doi: 10.1038/s41580-020-0250-z
   PubMed Web of Science ®Google Scholar
• Heberle AM, Prentzell MT, van Eunen K, et al. Molecular mechanisms of mTOR regulation by stress. Mol Cell Oncol. 2015;2(2):e970489. doi: 10.4161/23723548.2014.970489
   Google Scholar
• Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19(1):12. doi: 10.1186/s12943-020-1138-4
   PubMed Web of Science ®Google Scholar
• Zhu J, Thompson CB. Metabolic regulation of cell growth and proliferation. Nat Rev Mol Cell Biol. 2019;20(7):436–450. doi: 10.1038/s41580-019-0123-5
   PubMed Web of Science ®Google Scholar
• Folmes CD, Dzeja PP, Nelson TJ, et al. Metabolic plasticity in stem cell homeostasis and differentiation. Cell Stem Cell. 2012;11(5):596–606. doi: 10.1016/j.stem.2012.10.002
   PubMed Web of Science ®Google Scholar
• Tarazona OA, Pourquie O. Exploring the influence of cell metabolism on cell fate through protein post-translational modifications. Dev Cell. 2020;54(2):282–292. doi: 10.1016/j.devcel.2020.06.035
   Web of Science ®Google Scholar
• Matsumura T, Nakamura-Ishizu A, Muddineni S, et al. Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia. Blood. 2020;136(17):1919–1932. doi: 10.1182/blood.2019004292
   PubMed Web of Science ®Google Scholar
• Wortel IMN, van der Meer LT, Kilberg MS, et al. Surviving stress: modulation of ATF4-mediated stress responses in normal and malignant cells. Trends Endocrinol Metab. 2017;28(11):794–806. doi: 10.1016/j.tem.2017.07.003
   PubMed Web of Science ®Google Scholar
• Wolczyk M, Serwa R, Kominek A, et al. TIAR and FMRP shape pro-survival nascent proteome of leukemia cells in the bone marrow microenvironment. iScience. 2023;26(4):106543. doi: 10.1016/j.isci.2023.106543
   Google Scholar
• Lee S, Micalizzi D, Truesdell SS, et al. A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells. Genome Biol. 2020;21(1):33. doi: 10.1186/s13059-020-1936-4
   PubMed Web of Science ®Google Scholar
• Kilchert C, Strasser K, Kunetsky V, et al. From parts lists to functional significance-RNA-protein interactions in gene regulation. Wiley Interdiscip Rev RNA. 2020;11(3):e1582. doi: 10.1002/wrna.1582
   Web of Science ®Google Scholar
• Hentze MW, Castello A, Schwarzl T, et al. A brave new world of RNA-binding proteins. Nat Rev Mol Cell Biol. 2018;19(5):327–341. doi: 10.1038/nrm.2017.130
   PubMed Web of Science ®Google Scholar
• Muller-McNicoll M, Rossbach O, Hui J, et al. Auto-regulatory feedback by RNA-binding proteins. J Mol Cell Biol. 2019;11(10):930–939. doi: 10.1093/jmcb/mjz043
   PubMed Web of Science ®Google Scholar
• Quattrone A, Dassi E. The architecture of the human RNA-Binding protein regulatory network. iScience. 2019;21:706–719. doi: 10.1016/j.isci.2019.10.058
   Web of Science ®Google Scholar
• Wang E, Zhou H, Nadorp B, et al. Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation. Cell Stem Cell. 2021;28(4):718–31 e6. doi: 10.1016/j.stem.2020.12.005
   PubMed Web of Science ®Google Scholar
• Izquierdo JM, Valcarcel J. Two isoforms of the T-cell intracellular antigen 1 (TIA-1) splicing factor display distinct splicing regulation activities. Control of TIA-1 isoform ratio by TIA-1-related protein. J Biol Chem. 2007;282(27):19410–19417. doi: 10.1074/jbc.M700688200
   Web of Science ®Google Scholar
• Lee FCY, Ule J. Advances in CLIP technologies for studies of protein-RNA interactions. Mol Cell. 2018;69(3):354–369. doi: 10.1016/j.molcel.2018.01.005
   Web of Science ®Google Scholar
• Garcia-Maurino SM, Rivero-Rodriguez F, Velazquez-Cruz A, et al. RNA binding protein regulation and cross-talk in the control of AU-rich mRNA fate. Front Mol Biosci. 2017;4:71. doi: 10.3389/fmolb.2017.00071
   PubMed Web of Science ®Google Scholar
• Otsuka H, Fukao A, Funakami Y, et al. Emerging evidence of translational control by AU-Rich element-binding proteins. Front Genet. 2019;10:332. doi: 10.3389/fgene.2019.00332
   PubMed Web of Science ®Google Scholar
• Bakheet T, Williams BR, Khabar KS. ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res. 2006;34(Database issue):D111–4. doi: 10.1093/nar/gkj052
   Google Scholar
• Gruber AR, Fallmann J, Kratochvill F, et al. Aresite: a database for the comprehensive investigation of AU-rich elements. Nucleic Acids Res. 2011;39(Database issue):D66–9. doi: 10.1093/nar/gkq990
   Google Scholar
• Lebedeva S, Jens M, Theil K, et al. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol Cell. 2011;43(3):340–352. doi: 10.1016/j.molcel.2011.06.008
   PubMed Web of Science ®Google Scholar
• Binas O, Tants JN, Peter SA, et al. Structural basis for the recognition of transiently structured AU-rich elements by Roquin. Nucleic Acids Res. 2020;48(13):7385–7403. doi: 10.1093/nar/gkaa465
   Web of Science ®Google Scholar
• Tan D, Zhou M, Kiledjian M, et al. The ROQ domain of Roquin recognizes mRNA constitutive-decay element and double-stranded RNA. Nat Struct Mol Biol. 2014;21(8):679–685. doi: 10.1038/nsmb.2857
   PubMed Web of Science ®Google Scholar
• Podszywalow-Bartnicka P, Wolczyk M, Kusio-Kobialka M, et al. Downregulation of BRCA1 protein in BCR-ABL1 leukemia cells depends on stress-triggered TIAR-mediated suppression of translation. Cell Cycle. 2014;13(23):3727–3741. doi: 10.4161/15384101.2014.965013
   PubMed Web of Science ®Google Scholar
• Vujovic A, de Rooij L, Chahi AK, et al. In vivo screening unveils pervasive RNA-Binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target. Blood Cancer Discov. 2023;4(3):180–207. doi: 10.1158/2643-3230.BCD-22-0086
   Google Scholar
• Tang YJ, Wu W, Chen QQ, et al. miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-kappaB and JAK/STAT signaling pathways by targeting HuR. BMC Cancer. 2022;22(1):909. doi: 10.1186/s12885-022-09996-1
   Web of Science ®Google Scholar
• Bergalet J, Fawal M, Lopez C, et al. HuR-mediated control of C/EBPbeta mRNA stability and translation in ALK-positive anaplastic large cell lymphomas. Mol Cancer Res. 2011;9(4):485–496. doi: 10.1158/1541-7786.MCR-10-0351
   Web of Science ®Google Scholar
• Wang LJ, Lee YC, Chiou JT, et al. Effects of SIDT2 on the miR-25/NOX4/HuR axis and SIRT3 mRNA stability lead to ROS-mediated TNF-α expression in hydroquinone-treated leukemia cells. Cell Biol Toxicol. 2022;39(5):2207–2225. doi: 10.1007/s10565-022-09705-5
   Web of Science ®Google Scholar
• Young DJ, Stoddart A, Nakitandwe J, et al. Knockdown of Hnrnpa0, a del(5q) gene, alters myeloid cell fate in murine cells through regulation of AU-rich transcripts. Haematologica. 2014;99(6):1032–1040. doi: 10.3324/haematol.2013.098657
   Web of Science ®Google Scholar
• Cannell IG, Merrick KA, Morandell S, et al. A pleiotropic RNA-Binding protein controls distinct cell cycle checkpoints to drive resistance of p53-defective tumors to chemotherapy. Cancer Cell. 2015;28(5):623–637. doi: 10.1016/j.ccell.2015.09.009
   PubMed Web of Science ®Google Scholar
• Wilson GM, Lu J, Sutphen K, et al. Phosphorylation of p40AUF1 regulates binding to a + U-rich mRNA-destabilizing elements and protein-induced changes in ribonucleoprotein structure. J Biol Chem. 2003;278(35):33039–33048. doi: 10.1074/jbc.M305775200
   Web of Science ®Google Scholar
• Wilson GM, Lu J, Sutphen K, et al. Regulation of a + U-rich element-directed mRNA turnover involving reversible phosphorylation of AUF1. J Biol Chem. 2003;278(35):33029–33038. doi: 10.1074/jbc.M305772200
   Web of Science ®Google Scholar
• Fawal M, Armstrong F, Ollier S, et al. A “liaison dangereuse” between AUF1/hnRNPD and the oncogenic tyrosine kinase NPM-ALK. Blood. 2006;108(8):2780–2788. doi: 10.1182/blood-2006-04-014902
   Web of Science ®Google Scholar
• Zhang R, Lin P, Yang X, et al. Survival associated alternative splicing events in diffuse large B-cell lymphoma. Am J Transl Res. 2018;10(8):2636–2647.
   PubMed Web of Science ®Google Scholar
• Dolatshad H, Pellagatti A, Fernandez-Mercado M, et al. Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells. Leukemia. 2015;29(5):1092–1103. doi: 10.1038/leu.2014.331
   PubMed Web of Science ®Google Scholar
• Lima M. Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis. Orphanet J Rare Dis. 2013;8(1):95. doi: 10.1186/1750-1172-8-95
   PubMedGoogle Scholar
• Wolczyk M, Podszywalow-Bartnicka P, Bugajski L, et al. Stress granules assembly affects detection of mRNA in living cells by the NanoFlares; an important aspect of the technology. Biochim Biophys Acta Gen Subj. 2017;1861(5 Pt A):1024–1035. doi: 10.1016/j.bbagen.2017.02.010
   Web of Science ®Google Scholar
• Karmakar S, Ramirez O, Paul KV, et al. Integrative genome-wide analysis reveals EIF3A as a key downstream regulator of translational repressor protein Musashi 2 (MSI2). NAR Cancer. 2022;4(2):zcac015. doi: 10.1093/narcan/zcac015
   Google Scholar
• Ito T, Kwon HY, Zimdahl B, et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature. 2010;466(7307):765–768. doi: 10.1038/nature09171
   PubMed Web of Science ®Google Scholar
• Kharas MG, Lengner CJ, Al-Shahrour F, et al. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat Med. 2010;16(8):903–908. doi: 10.1038/nm.2187
   PubMed Web of Science ®Google Scholar
• Griner LN, Reuther GW. Aggressive myeloid leukemia formation is directed by the Musashi 2/Numb pathway. Cancer Biol Ther. 2010;10(10):979–982. doi: 10.4161/cbt.10.10.14010
   PubMed Web of Science ®Google Scholar
• Han Y, Ye A, Zhang Y, et al. Musashi-2 silencing exerts potent activity against acute myeloid leukemia and enhances chemosensitivity to Daunorubicin. PLOS ONE. 2015;10(8):e0136484. doi: 10.1371/journal.pone.0136484
   Web of Science ®Google Scholar
• Kwon HY, Bajaj J, Ito T, et al. Tetraspanin 3 is required for the development and propagation of acute myelogenous leukemia. Cell Stem Cell. 2015;17(2):152–164. doi: 10.1016/j.stem.2015.06.006
   PubMed Web of Science ®Google Scholar
• Vu LP, Prieto C, Amin EM, et al. Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells. Nat Genet. 2017;49(6):866–875. doi: 10.1038/ng.3854
   PubMed Web of Science ®Google Scholar
• Rounbehler RJ, Fallahi M, Yang C, et al. Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state. Cell. 2012;150(3):563–574. doi: 10.1016/j.cell.2012.06.033
   Web of Science ®Google Scholar
• Kagoya Y, Nakatsugawa M, Ochi T, et al. Transient stimulation expands superior antitumor T cells for adoptive therapy. JCI Insight. 2017;2(2):e89580. doi: 10.1172/jci.insight.89580
   Web of Science ®Google Scholar
• Kaehler M, Dworschak M, Rodin JP, et al. ZFP36L1 plays an ambiguous role in the regulation of cell expansion and negatively regulates CDKN1A in chronic myeloid leukemia cells. Exp Hematol. 2021;99:54–64 e7. doi: 10.1016/j.exphem.2021.05.006
   Web of Science ®Google Scholar
• Jeltsch KM, Hu D, Brenner S, et al. Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation. Nat Immunol. 2014;15(11):1079–1089. doi: 10.1038/ni.3008
   PubMed Web of Science ®Google Scholar
• Wimberger N, Ober F, Avar G, et al. Oncogene-induced MALT1 protease activity drives post-transcriptional gene expression in malignant lymphomas. Blood. 2023;142(23):1985–2001. doi: 10.1182/blood.2023021299
   Web of Science ®Google Scholar
• Kidoya H, Muramatsu F, Shimamura T, et al. Regnase-1-mediated post-transcriptional regulation is essential for hematopoietic stem and progenitor cell homeostasis. Nat Commun. 2019;10(1):1072. doi: 10.1038/s41467-019-09028-w
   PubMedGoogle Scholar
• Okuda H, Miyamoto R, Takahashi S, et al. RNA-binding proteins of KHDRBS and IGF2BP families control the oncogenic activity of MLL-AF4. Nat Commun. 2022;13(1):6688. doi: 10.1038/s41467-022-34558-1
   PubMed Web of Science ®Google Scholar
• Sumithra B, Saxena U, Das AB. A comprehensive study on genome-wide coexpression network of KHDRBS1/Sam68 reveals its cancer and patient-specific association. Sci Rep. 2019;9(1):11083. doi: 10.1038/s41598-019-47558-x
   PubMedGoogle Scholar
• Wang Q, Li Y, Cheng J, et al. Sam68 affects cell proliferation and apoptosis of human adult T-acute lymphoblastic leukemia cells via AKT/mTOR signal pathway. Leuk Res. 2016;46:1–9.
   Web of Science ®Google Scholar
• Xu J, Wang D, Ma H, et al. KHSRP combines transcriptional and posttranscriptional mechanisms to regulate monocytic differentiation. Blood Sci. 2022;4(3):103–115. doi: 10.1097/BS9.0000000000000122
   Google Scholar
• Kafer R, Schmidtke L, Schrick K, et al. The RNA-Binding protein KSRP modulates cytokine expression of CD4(+) T cells. J Immunol Res. 2019;2019:4726532.
   Web of Science ®Google Scholar
• Zhang Y, Peng L, Hu T, et al. La-related protein 4B maintains murine MLL-AF9 leukemia stem cell self-renewal by regulating cell cycle progression. Exp Hematol. 2015;43(4):309–18 e2. doi: 10.1016/j.exphem.2014.12.003
   PubMed Web of Science ®Google Scholar
• Corley M, Burns MC, Yeo GW. How RNA-Binding proteins interact with RNA: molecules and mechanisms. Mol Cell. 2020;78(1):9–29. doi: 10.1016/j.molcel.2020.03.011
   PubMed Web of Science ®Google Scholar
• Meyer C, Garzia A, Mazzola M, et al. The TIA1 RNA-Binding protein family regulates EIF2AK2-mediated stress response and cell cycle progression. Mol Cell. 2018;69(4):622–35 e6. doi: 10.1016/j.molcel.2018.01.011
   Web of Science ®Google Scholar
• Del Gatto-Konczak F, Bourgeois CF, Le Guiner C, et al. The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5’ splice site. Mol Cell Biol. 2000;20(17):6287–6299. doi: 10.1128/MCB.20.17.6287-6299.2000
   PubMed Web of Science ®Google Scholar
• Forch P, Puig O, Martinez C, et al. The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5’ splice sites. Embo J. 2002;21(24):6882–6892. doi: 10.1093/emboj/cdf668
   PubMed Web of Science ®Google Scholar
• Gal-Mark N, Schwartz S, Ram O, et al. The pivotal roles of TIA proteins in 5’ splice-site selection of alu exons and across evolution. PLOS Genet. 2009;5(11):e1000717. doi: 10.1371/journal.pgen.1000717
   Web of Science ®Google Scholar
• Wang Z, Kayikci M, Briese M, et al. iCLIP predicts the dual splicing effects of TIA-RNA interactions. PLOS Biol. 2010;8(10):e1000530. doi: 10.1371/journal.pbio.1000530
   Web of Science ®Google Scholar
• Mukherjee N, Corcoran DL, Nusbaum JD, et al. Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability. Mol Cell. 2011;43(3):327–339. doi: 10.1016/j.molcel.2011.06.007
   PubMed Web of Science ®Google Scholar
• Li Y, Estep JA, Karginov FV. Transcriptome-wide identification and validation of interactions between the miRNA machinery and HuR on mRNA targets. J Mol Biol. 2018;430(3):285–296. doi: 10.1016/j.jmb.2017.12.006
   PubMed Web of Science ®Google Scholar
• Yoon JH, De S, Srikantan S, et al. PAR-CLIP analysis uncovers AUF1 impact on target RNA fate and genome integrity. Nat Commun. 2014;5(1):5248. doi: 10.1038/ncomms6248
   Google Scholar
• Myer VE, Steitz JA. Isolation and characterization of a novel, low abundance hnRNP protein: A0. RNA. 1995;1(2):171–182.
   PubMed Web of Science ®Google Scholar
• Thibault PA, Ganesan A, Kalyaanamoorthy S, et al. hnRNP A/B proteins: an encyclopedic assessment of their roles in homeostasis and disease. Biology. 2021;10(8):712. doi: 10.3390/biology10080712
   Google Scholar
• Briata P, Bordo D, Puppo M, et al. Diverse roles of the nucleic acid-binding protein KHSRP in cell differentiation and disease. Wiley Interdiscip Rev RNA. 2016;7(2):227–240. doi: 10.1002/wrna.1327
   Web of Science ®Google Scholar
• Briata P, Chen CY, Ramos A, et al. Functional and molecular insights into KSRP function in mRNA decay. Biochim Biophys Acta. 2013;1829(6–7):689–694. doi: 10.1016/j.bbagrm.2012.11.003
   Web of Science ®Google Scholar
• Feracci M, Foot JN, Grellscheid SN, et al. Structural basis of RNA recognition and dimerization by the STAR proteins T-STAR and Sam68. Nat Commun. 2016;7(1):10355. doi: 10.1038/ncomms10355
   Google Scholar
• Duggimpudi S, Kloetgen A, Maney SK, et al. Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2‘s RNA-binding activity on IL-6 signaling. J Biol Chem. 2018;293(40):15359–15369. doi: 10.1074/jbc.RA118.002243
   Web of Science ®Google Scholar
• Kuspert M, Murakawa Y, Schaffler K, et al. LARP4B is an AU-rich sequence associated factor that promotes mRNA accumulation and translation. RNA. 2015;21(7):1294–1305. doi: 10.1261/rna.051441.115
   PubMed Web of Science ®Google Scholar
• Maraia RJ, Mattijssen S, Cruz-Gallardo I, et al. The La and related RNA-binding proteins (LARPs): structures, functions, and evolving perspectives. Wiley Interdiscip Rev RNA. 2017;8(6). doi: 10.1002/wrna.1430
   Web of Science ®Google Scholar
• Mao R, Yang R, Chen X, et al. Regnase-1, a rapid response ribonuclease regulating inflammation and stress responses. Cell Mol Immunol. 2017;14(5):412–422. doi: 10.1038/cmi.2016.70
   Web of Science ®Google Scholar
• Mino T, Takeuchi O. Regnase-1 and Roquin regulate inflammatory mRNAs. Oncotarget. 2015;6(20):17869–17870. doi: 10.18632/oncotarget.4891
   Google Scholar
• Nwosu GO, Powell JA, Pitson SM. Targeting the integrated stress response in hematologic malignancies. Exp Hematol Oncol. 2022;11(1):94. doi: 10.1186/s40164-022-00348-0
   Web of Science ®Google Scholar
• Sanduja S, Blanco FF, Dixon DA. The roles of TTP and BRF proteins in regulated mRNA decay. Wiley Interdiscip Rev RNA. 2011;2(1):42–57. doi: 10.1002/wrna.28
   PubMed Web of Science ®Google Scholar
• Ma W, Zhen G, Xie W, et al. In vivo reconstitution finds multivalent RNA–RNA interactions as drivers of mesh-like condensates. Elife. 2021;10:10. doi: 10.7554/eLife.64252
   Web of Science ®Google Scholar
• Ma W, Mayr C. A membraneless organelle associated with the endoplasmic reticulum enables 3‘UTR-Mediated protein-protein interactions. Cell. 2018;175(6):1492–506 e19. doi: 10.1016/j.cell.2018.10.007
   PubMed Web of Science ®Google Scholar
• Newton K, Dixit VM. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol. 2012;4(3):a006049–a006049. doi: 10.1101/cshperspect.a006049
   PubMed Web of Science ®Google Scholar
• Wang J, Erlacher M, Fernandez-Orth J. The role of inflammation in hematopoiesis and bone marrow failure: what can we learn from mouse models? Front Immunol. 2022;13:951937. doi: 10.3389/fimmu.2022.951937
   PubMed Web of Science ®Google Scholar
• Ratajczak MZ, Kucia M. Hematopoiesis and innate immunity: an inseparable couple for good and bad times, bound together by an hormetic relationship. Leukemia. 2022;36(1):23–32. doi: 10.1038/s41375-021-01482-0
   Web of Science ®Google Scholar
• Goncalves AC, Cortesao E, Oliveiros B, et al. Oxidative stress and mitochondrial dysfunction play a role in myelodysplastic syndrome development, diagnosis, and prognosis: a pilot study. Free Radic Res. 2015;49(9):1081–1094. doi: 10.3109/10715762.2015.1035268
   Web of Science ®Google Scholar
• van Galen P, Mbong N, Kreso A, et al. Integrated stress response activity marks stem cells in normal hematopoiesis and leukemia. Cell Rep. 2018;25(5):1109–17 e5. doi: 10.1016/j.celrep.2018.10.021
   Web of Science ®Google Scholar
• Follo MY, Finelli C, Mongiorgi S, et al. PKR is activated in MDS patients and its subcellular localization depends on disease severity. Leukemia. 2008;22(12):2267–2269. doi: 10.1038/leu.2008.122
   Web of Science ®Google Scholar
• Blalock WL, Grimaldi C, Fala F, et al. PKR activity is required for acute leukemic cell maintenance and growth: a role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation. J Cell Physiol. 2009;221(1):232–241. doi: 10.1002/jcp.21848
   Web of Science ®Google Scholar
• Cheng X, Byrne M, Brown KD, et al. PKR inhibits the DNA damage response, and is associated with poor survival in AML and accelerated leukemia in NHD13 mice. Blood. 2015;126(13):1585–1594. doi: 10.1182/blood-2015-03-635227
   Web of Science ®Google Scholar
• Piwocka K, Vejda S, Cotter TG, et al. Bcr-Abl reduces endoplasmic reticulum releasable calcium levels by a Bcl-2-independent mechanism and inhibits calcium-dependent apoptotic signaling. Blood. 2006;107(10):4003–4010. doi: 10.1182/blood-2005-04-1523
   Web of Science ®Google Scholar
• Kusio-Kobialka M, Podszywalow-Bartnicka P, Peidis P, et al. The PERK-eIf2alpha phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells. Cell Cycle. 2012;11(21):4069–4078. doi: 10.4161/cc.22387
   PubMed Web of Science ®Google Scholar
• Dudka W, Hoser G, Mondal SS, et al. Targeting integrated stress response with ISRIB combined with imatinib treatment attenuates RAS/RAF/MAPK and STAT5 signaling and eradicates chronic myeloid leukemia cells. BMC Cancer. 2022;22(1):1254. doi: 10.1186/s12885-022-10289-w
   Web of Science ®Google Scholar
• Biancon G, Joshi P, Zimmer JT, et al. Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies. Mol Cell. 2022;82(6):1107–22 e7. doi: 10.1016/j.molcel.2022.02.025
   Web of Science ®Google Scholar
• Diaz-Munoz MD, Kiselev VY, Le Novere N, et al. Tia1 dependent regulation of mRNA subcellular location and translation controls p53 expression in B cells. Nat Commun. 2017;8(1):530. doi: 10.1038/s41467-017-00454-2
   Google Scholar
• Bonomo I, Assoni G, La Pietra V, et al. HuR modulation counteracts lipopolysaccharide response in murine macrophages. Dis Model Mech. 2023;16(3): doi: 10.1242/dmm.050120
   Web of Science ®Google Scholar
• Hu X, Li J, Fu M, et al. The JAK/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021;6(1):402. doi: 10.1038/s41392-021-00791-1
   PubMed Web of Science ®Google Scholar
• Zhang T, Ma C, Zhang Z, et al. NF-kappaB signaling in inflammation and cancer. MedComm. 2021;2(4):618–653. doi: 10.1002/mco2.104
   PubMedGoogle Scholar
• Kudinov AE, Karanicolas J, Golemis EA, et al. Musashi RNA-Binding proteins as cancer drivers and novel therapeutic targets. Clin Cancer Res. 2017;23(9):2143–2153. doi: 10.1158/1078-0432.CCR-16-2728
   PubMed Web of Science ®Google Scholar
• Majeti R, Jamieson C, Pang WW, et al. Clonal expansion of Stem/Progenitor cells in cancer, fibrotic diseases, and atherosclerosis, and CD47 protection of pathogenic cells. Annu Rev Med. 2022;73(1):307–320. doi: 10.1146/annurev-med-042420-104436
   Google Scholar
• Leppek K, Schott J, Reitter S, et al. Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs. Cell. 2013;153(4):869–881. doi: 10.1016/j.cell.2013.04.016
   PubMed Web of Science ®Google Scholar
• Hauer J, Fischer U, Borkhardt A. Toward prevention of childhood ALL by early-life immune training. Blood. 2021;138(16):1412–1428. doi: 10.1182/blood.2020009895
   Web of Science ®Google Scholar
• Carbone A, Tripodo C, Carlo-Stella C, et al. The role of inflammation in lymphoma. Adv Exp Med Biol. 2014;816:315–333.
   PubMed Web of Science ®Google Scholar
• Popovic B, Nicolet BP, Guislain A, et al. Time-dependent regulation of cytokine production by RNA binding proteins defines T cell effector function. Cell Rep. 2023;42(5):112419. doi: 10.1016/j.celrep.2023.112419
   Web of Science ®Google Scholar
• Heeren JJ F-V. Post-transcriptional control of T-cell cytokine production: implications for cancer therapy. Immunology. 2021;164(1):57–72. doi: 10.1111/imm.13339
   Web of Science ®Google Scholar
• Gillis P, Malter JS. The adenosine-uridine binding factor recognizes the AU-rich elements of cytokine, lymphokine, and oncogene mRnas. J Biol Chem. 1991;266(5):3172–3177. doi: 10.1016/S0021-9258(18)49970-X
   PubMed Web of Science ®Google Scholar
• Curdy N, Lanvin O, Cadot S, et al. Stress granules in the post-transcriptional regulation of immune cells. Front Cell Dev Biol. 2020;8:611185. doi: 10.3389/fcell.2020.611185
   Web of Science ®Google Scholar
• Naz S, Battu S, Khan RA, et al. Activation of integrated stress response pathway regulates IL-1beta production through posttranscriptional and translational reprogramming in macrophages. Eur J Immunol. 2019;49(2):277–289. doi: 10.1002/eji.201847513
   Web of Science ®Google Scholar
• Paget M, Cadena C, Ahmad S, et al. Stress granules are shock absorbers that prevent excessive innate immune responses to dsRNA. Mol Cell. 2023;83(7):1180–96 e8. doi: 10.1016/j.molcel.2023.03.010
   Web of Science ®Google Scholar
• Kong G, Dou Y, Xiao X, et al. Transgenic expression of a Mutant Ribonuclease Regnase-1 in T cells disturbs T cell development and functions. Front Immunol. 2021;12:682220. doi: 10.3389/fimmu.2021.682220
   Web of Science ®Google Scholar
• Bhat N, Virgen-Slane R, Ramezani-Rad P, et al. Regnase-1 is essential for B cell homeostasis to prevent immunopathology. J Exp Med. 2021;218(5): doi: 10.1084/jem.20200971
   Web of Science ®Google Scholar
• Moore MJ, Blachere NE, Fak JJ, et al. ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity. Elife. 2018;7. doi: 10.7554/eLife.33057
   Web of Science ®Google Scholar
• Ott G, Rosenwald A, Campo E. Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. Blood. 2013;122(24):3884–3891. doi: 10.1182/blood-2013-05-498329
   PubMed Web of Science ®Google Scholar
• Izquierdo JM, Majos N, Bonnal S, et al. Regulation of fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol Cell. 2005;19(4):475–484. doi: 10.1016/j.molcel.2005.06.015
   PubMed Web of Science ®Google Scholar
• Izquierdo JM. Hu antigen R (HuR) functions as an alternative pre-mRNA splicing regulator of fas apoptosis-promoting receptor on exon definition. J Biol Chem. 2008;283(27):19077–19084. doi: 10.1074/jbc.M800017200
   PubMed Web of Science ®Google Scholar
• Villa-Morales M, Cobos MA, Gonzalez-Gugel E, et al. FAS system deregulation in T-cell lymphoblastic lymphoma. Cell Death Dis. 2014;5(3):e1110. doi: 10.1038/cddis.2014.83
   Google Scholar
• Razzaghi R, Agarwal S, Kotlov N, et al. Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphoma. J Exp Med. 2021;218(3): doi: 10.1084/jem.20201173
   Web of Science ®Google Scholar
• Diaz-Munoz MD, Bell SE, Fairfax K, et al. The RNA-binding protein HuR is essential for the B cell antibody response. Nat Immunol. 2015;16(4):415–425. doi: 10.1038/ni.3115
   PubMed Web of Science ®Google Scholar
• Papadaki O, Milatos S, Grammenoudi S, et al. Control of thymic T cell maturation, deletion and egress by the RNA-binding protein HuR. J Immunol. 2009;182(11):6779–6788. doi: 10.4049/jimmunol.0900377
   PubMed Web of Science ®Google Scholar
• Yu S, Tripod M, Atasoy U, et al. HuR plays a positive role to strengthen the signaling pathways of CD4(+) T cell activation and Th17 cell differentiation. J Immunol Res. 2021;2021:9937243. doi: 10.1155/2021/9937243
   Google Scholar
• Vivori C, Papasaikas P, Stadhouders R, et al. Dynamics of alternative splicing during somatic cell reprogramming reveals functions for RNA-binding proteins CPSF3, hnRNP UL1, and TIA1. Genome Biol. 2021;22(1):171. doi: 10.1186/s13059-021-02372-5
   PubMed Web of Science ®Google Scholar
• Kurata M, Onishi I, Takahara T, et al. C/EBPbeta induces B-cell acute lymphoblastic leukemia and cooperates with BLNK mutations. Cancer Sci. 2021;112(12):4920–4930. doi: 10.1111/cas.15164
   Web of Science ®Google Scholar
• Piva R, Pellegrino E, Mattioli M, et al. Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. J Clin Invest. 2006;116(12):3171–3182. doi: 10.1172/JCI29401
   PubMed Web of Science ®Google Scholar
• Stelmach P, Trumpp A. Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica. 2023;108(2):353–366. doi: 10.3324/haematol.2022.280800
   PubMed Web of Science ®Google Scholar
• Hubstenberger A, Courel M, Benard M, et al. P-Body purification reveals the condensation of repressed mRNA regulons. Mol Cell. 2017;68(1):144–57 e5. doi: 10.1016/j.molcel.2017.09.003
   PubMed Web of Science ®Google Scholar
• Sanchez-Jimenez C, Ludena MD, Izquierdo JM. T-cell intracellular antigens function as tumor suppressor genes. Cell Death Dis. 2015;6(3):e1669. doi: 10.1038/cddis.2015.43
   Google Scholar
• Sung HM, Schott J, Boss P, et al. Stress-induced nuclear speckle reorganization is linked to activation of immediate early gene splicing. J Cell Bio. 2023;222(12): doi: 10.1083/jcb.202111151
   Web of Science ®Google Scholar
• Galloway A, Saveliev A, Lukasiak S, et al. RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence. Science. 2016;352(6284):453–459. doi: 10.1126/science.aad5978
   PubMed Web of Science ®Google Scholar
• Kesarwani M, Kincaid Z, Gomaa A, et al. Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia. Nat Med. 2017;23(4):472–482. doi: 10.1038/nm.4310
   Web of Science ®Google Scholar
• Reinhardt HC, Hasskamp P, Schmedding I, et al. DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization. Mol Cell. 2010;40(1):34–49. doi: 10.1016/j.molcel.2010.09.018
   PubMed Web of Science ®Google Scholar
• Kaloni D, Diepstraten ST, Strasser A, et al. BCL-2 protein family: attractive targets for cancer therapy. Apoptosis. 2023;28(1–2):20–38. doi: 10.1007/s10495-022-01780-7
   PubMed Web of Science ®Google Scholar
• Stella S, Tirro E, Conte E, et al. Suppression of survivin induced by a BCR-ABL/JAK2/STAT3 pathway sensitizes imatinib-resistant CML cells to different cytotoxic drugs. Mol Cancer Ther. 2013;12(6):1085–1098. doi: 10.1158/1535-7163.MCT-12-0550
   PubMed Web of Science ®Google Scholar
• Carter BZ, Mak PY, Mu H, et al. Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells. Sci Transl Med. 2016;8(355):355ra117. doi: 10.1126/scitranslmed.aag1180
   PubMed Web of Science ®Google Scholar
• Roberts AW, Wei AH, Huang DCS. BCL2 and MCL1 inhibitors for hematologic malignancies. Blood. 2021;138(13):1120–1136. doi: 10.1182/blood.2020006785
   PubMed Web of Science ®Google Scholar
• Aichberger KJ, Mayerhofer M, Krauth MT, et al. Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides. Blood. 2005;105(8):3303–3311. doi: 10.1182/blood-2004-02-0749
   PubMed Web of Science ®Google Scholar
• Donahue JM, Chang ET, Xiao L, et al. The RNA-binding protein HuR stabilizes survivin mRNA in human oesophageal epithelial cells. Biochem J. 2011;437(1):89–96. doi: 10.1042/BJ20110028
   PubMedGoogle Scholar
• Filippova N, Yang X, Wang Y, et al. The RNA-binding protein HuR promotes glioma growth and treatment resistance. Mol Cancer Res. 2011;9(5):648–659. doi: 10.1158/1541-7786.MCR-10-0325
   PubMed Web of Science ®Google Scholar
• Abdelmohsen K, Pullmann R Jr., Lal A, et al. Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell. 2007;25(4):543–557. doi: 10.1016/j.molcel.2007.01.011
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Dehnad A, Fish S, et al. NOX4 regulates CCR2 and CCL2 mRNA stability in alcoholic liver disease. Sci Rep. 2017;7(1):46144. doi: 10.1038/srep46144
   Google Scholar
• Macanas-Pirard P, Quezada T, Navarrete L, et al. The CCL2/CCR2 axis affects transmigration and proliferation but not resistance to chemotherapy of acute myeloid leukemia cells. PLOS ONE. 2017;12(1):e0168888. doi: 10.1371/journal.pone.0168888
   PubMed Web of Science ®Google Scholar
• Xiao X, Xu Q, Sun Y, et al. 5‑aza‑2‘‑deoxycytidine promotes migration of acute monocytic leukemia cells via activation of CCL2‑CCR2‑ERK signaling pathway. Mol Med Rep. 2017;16(2):1417–1424. doi: 10.3892/mmr.2017.6737
   Web of Science ®Google Scholar
• Cappell KM, Kochenderfer JN. Long-term outcomes following CAR T cell therapy: what we know so far. Nat Rev Clin Oncol. 2023;20(6):359–371. doi: 10.1038/s41571-023-00754-1
   PubMed Web of Science ®Google Scholar
• Wei J, Long L, Zheng W, et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019;576(7787):471–476. doi: 10.1038/s41586-019-1821-z
   PubMed Web of Science ®Google Scholar
• Mai D, Johnson O, Reff J, et al. Combined disruption of T cell inflammatory regulators regnase-1 and roquin-1 enhances antitumor activity of engineered human T cells. Proc Natl Acad Sci U S A. 2023;120(12):e2218632120. doi: 10.1073/pnas.2218632120
   Google Scholar
• Zheng W, Wei J, Zebley CC, et al. Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALL. Blood. 2021;138(2):122–135. doi: 10.1182/blood.2020009309
   Web of Science ®Google Scholar
• Liu Y, Li X, Zhang H, et al. HuR up-regulates cell surface PD-L1 via stabilizing CMTM6 transcript in cancer. Oncogene. 2021;40(12):2230–2242. doi: 10.1038/s41388-021-01689-6
   PubMed Web of Science ®Google Scholar
• Cao X, Wang Y, Zhang W, et al. Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced immunosuppression. Blood. 2022;139(22):3290–3302. doi: 10.1182/blood.2021013901
   Web of Science ®Google Scholar